Alan Fournier's portfolio and holdings - Mar 2024

As per corporate shareholdings filed for , people matching Alan Fournier publicly holds 35 stocks with a net worth of over US$ 592.6 M.

These are shares held by Alan Fournier as per the shareholding data filed with the exchanges. The latest quarter tends to have missing data since not all companies may have reported their shareholding data till now.

ADD ALL SUPERSTAR ALERTS
Stock Name Holders Name Current Price US$ Quantity Held Holding Percent Change from Previous Qtr Holding Value US$ History
Perimeter Solutions SA Pennant Investors Lp 22.76 2,300,000 1.58% NEW 52.3 M
ODP Corporation (The) Pennant Investors Lp 27.77 400,000 1.19% 0.09 11.1 M
EchoStar Corp - Ordinary Shares - Class A Pennant Investors Lp 73.45 2,153,209 0.79% 0.00 158.2 M
FibroGen Inc Pennant Investors Lp 11.35 768,400 0.77% 0.00 8.7 M
Enovis Corp Pennant Investors Lp 32.49 400,000 0.73% NEW 13.0 M
Antero Resources Corp Pennant Investors Lp 31.97 1,133,000 0.36% 0.07 36.2 M
BioXcel Therapeutics Inc Pennant Investors Lp 2.33 83,900 0.23% 0.00 195.5 K
Seres Therapeutics Inc Pennant Investors Lp 18.55 292,300 0.19% 0.00 5.4 M
Kalaris Therapeutics Inc. Pennant Investors Lp 4.92 215,700 0.19% 0.00 1.1 M
Enanta Pharmaceuticals Inc Pennant Investors Lp 11.16 35,100 0.17% 0.00 391.7 K
Altimmune Inc Pennant Investors Lp 3.96 109,800 0.15% 0.00 434.8 K
Arcutis Biotherapeutics Inc Pennant Investors Lp 20.73 170,900 0.15% 0.00 3.5 M
Coherus Biosciences Inc Pennant Investors Lp 1.77 168,100 0.15% 0.00 297.5 K
Compass Therapeutics Inc Pennant Investors Lp 4.07 199,000 0.14% 0.00 809.9 K
Fate Therapeutics Inc Pennant Investors Lp 1.51 146,100 0.13% 0.00 220.6 K
Agenus Inc Pennant Investors Lp 4.45 469,600 0.11% 0.00 2.1 M
uniQure N.V. Pennant Investors Lp 63.03 48,500 0.10% 0.00 3.1 M
Nurix Therapeutics Inc Pennant Investors Lp 10.36 56,800 0.09% 0.00 588.4 K
Transdigm Group Incorporated Pennant Investors Lp 1302.24 42,000 0.07% 0.00 54.7 M
Macrogenics Inc Pennant Investors Lp 1.74 43,800 0.07% 0.00 76.2 K
Allogene Therapeutics Inc Pennant Investors Lp 1.28 128,400 0.06% -0.01 164.4 K
Erasca Inc Pennant Investors Lp 2.44 166,200 0.06% -0.05 405.5 K
Zymeworks BC Inc Pennant Investors Lp 18.59 38,700 0.05% 0.00 719.4 K
Arcturus Therapeutics Holdings Inc Pennant Investors Lp 21.64 13,100 0.05% 0.00 283.5 K
Zentalis Pharmaceuticals Inc Pennant Investors Lp 1.56 32,400 0.05% 0.00 50.5 K
Replimune Group Inc Pennant Investors Lp 9.27 30,500 0.04% -0.01 282.7 K
89bio Inc Pennant Investors Lp 14.79 44,500 0.04% 0.00 658.2 K
Novavax, Inc. Pennant Investors Lp 8.70 60,300 0.04% -0.01 524.6 K
Relay Therapeutics Inc Pennant Investors Lp 6.95 42,400 0.03% 0.00 294.7 K
Micron Technology Inc. Pennant Investors Lp 205.74 306,000 0.03% 0.00 63.0 M
Agios Pharmaceuticals Inc Pennant Investors Lp 42.37 15,100 0.03% 0.00 639.8 K
Arcus Biosciences Inc Pennant Investors Lp 17.14 23,700 0.03% 0.00 406.2 K
Amazon.com Inc. Pennant Investors Lp 215.88 296,000 0.00% 0.00 63.9 M
Alphabet Inc - Ordinary Shares - Class A Pennant Investors Lp 256.16 199,000 0.00% 0.00 51.0 M
Microsoft Corporation Pennant Investors Lp 517.31 112,000 0.00% 0.00 57.9 M
View All The Superstar Shareholder Portfolios